Most people are willing to invest in their health — but investing in healthcare stocks is a different story.
As investors, we look for businesses built on stability, not speculation.

While Wall Street chases the next “revolutionary” biotech with 100x potential, the reality is often a coin toss.
We’re more interested in a steady, overlooked healthcare company quietly building vertical integration — the kind of progress that doesn’t vanish overnight.

📈The Stock: Al-Dawaa (4163.SR)

Al-Dawaa operates over 900 physical pharmacies and has steadily expanded into multiple layers of the healthcare industry

Healthcare Logistics → Built Proceed, a logistics arm powering nationwide distribution

Medical Device Manufacturing → Owns PREMI for healthcare equipment

Public Sector Fulfillment → 70% of all prescriptions in Saudi Arabia

This is a deeply entrenched, high-retention business—not just selling products, but playing a central role in the country’s healthcare infrastructure.
And with its logistics capabilities, Al-Dawaa gains a defensible moat most retailers can’t match.

In Short: The country needs them to be healthy

💰Show me The Money

Metric

2022

2023

2024

Profit Margin (%)

5.73

5.74

5.74

Debt To Equity

3.11

2.59

2.46

Return On Equity(%)

30.06

28.19

26.09

Ownership also comes with a 3.22% dividend yield — a rare bonus in a growing healthcare business.

With improving financials and a strong foundation already in place, management now has the flexibility to deploy excess cash strategically, including reducing the debt-to-equity ratio and strengthening the balance sheet further.

See You Next Sunday!

More From Capital

No posts found